Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 176

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Anxious and depressive symptoms in Parkinson's disease: The French cross‐sectionnal DoPaMiP study

Nègre‐Pagès, Laurence, Grandjean, Hélène, Lapeyre‐Mestre, Maryse, Montastruc, Jean Louis, Fourrier, Annie, Lépine, Jean Pierre, Rascol, Oliver, on behalf of the DoPaMiP Study Group · 2010 · Movement Disorders

Abstract

Anxiety has been less extensively studied than depression in Parkinson's disease (PD). The DoPaMiP survey allowed assessing simultaneously anxiety and depressive symptoms in PD and comparing correlations of both symptoms with clinical and therapeutic features of the disease. Cross sectional survey conducted prospectively in 450 ambulatory nondemented PD patients and 98 patients with other disorders than PD. Anxiety and depressive symptoms were assessed using the Hospital Anxiety and Depression Scale (HADS), parkinsonism using the Unified Parkinson's Disease Rating Scale (UPDRS). Other clinical factors were measured using a structured standardized examination/questionnaire. The mean HADS‐A (anxiety) subscore was higher in PD patients than in the others (8.2 ± 3.9 vs. 6.5 ± 3.2, P < 10−4) as was the HADS‐D (depressive) subscore (6.6 ± 3.8 vs. 3.9 ± 3.2, P < 10−4). Patients with possible/probable anxious signs (HADS‐A ≥ 8) were more prevalent in PD (51% vs. 29%, P < 10−4) as were those with depressive symptoms (40% vs. 10%, P < 10−4). Conversely, anxiolytic and antidepressant medications consumption was not different between the 2 groups. Patients with anxious symptoms were more frequently female and younger than those without such symptoms, while those with depressive symptoms had more severe indices of parkinsonism, more comorbidities and lower cognitive function (Mini Mental State Exam). The logistic regression model revealed that patients with depressive symptoms received more frequently levodopa and less frequently a dopamine agonist. Anxiety and depressive symptoms were more frequent in PD patients than in medical control group. Both symptoms were commonly associated in the same PD patients, but were correlated with different clinical/therapeutic features, suggesting different underlying pathophysiological mechanisms. © 2009 Movement Disorder Society

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/mds.22760

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 176

Metadata

Authors
Nègre‐Pagès, L., Grandjean, H., Lapeyre‐Mestre, M., Montastruc, J. L., Fourrier, A., Lépine, J. P., Rascol, O., & on behalf of the DoPaMiP Study Group
Venue
Movement Disorders
Publisher
Wiley
Published
2010-01-30
Volume
25
Issue
2
Pages
157-166
ISSN
  • 0885-3185 (ISSN-L)
  • 1531-8257
OpenAlex
W2057668497
Cited by
176
References
9
FWCI
5.63
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anxious and depressive symptoms in Parkinson's disease: The French cross‐sectionnal DoPaMiP study. https://app.cochat.ai/papers/10.1002/mds.22760
The paper
Nègre‐Pagès, L., Grandjean, H., Lapeyre‐Mestre, M., Montastruc, J. L., Fourrier, A., Lépine, J. P., Rascol, O., & on behalf of the DoPaMiP Study Group. (2010). Anxious and depressive symptoms in Parkinson's disease: The French cross‐sectionnal DoPaMiP study. Movement Disorders. https://doi.org/10.1002/mds.22760

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.